insights_auto
Prečo akcie ALMKT klesli 3,38%?
Preskúmať podrobnejšiechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,12 €
arrow_downward
-3,38%(-0,0042) 1 d.
5. 10., 17:35:04 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre ALMKT…
Otvoriť
0,13 €
Vysoká
0,13 €
Nízka
0,12 €
Trh. kap.
24,25 mil.
Priem. obj.
440,14 tis.
Objem
560,78 tis.
Pomer cena/zárobky
0,98
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
59
Otvoriť
0,13 €
Vysoká
0,13 €
Nízka
0,12 €
Trh. kap.
24,25 mil.
Priem. obj.
440,14 tis.
Objem
560,78 tis.
Pomer cena/zárobky
0,98
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
59
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Carroll County Mirror-Democrat
·
pred 1 hodinou
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq
Stock Titan
·
pred 7 minútami
Five new hires’ options vest over four years, if they stay
Yahoo Finance
·
pred 38 minútami
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns
Seeking Alpha
·
pred 56 minútami
Record 72 S&P 500 firms issue positive Q3 earnings guidance - FactSet (SPY:NYSEARCA)
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Informácie o subjekte Mauna Kea Technologies SA
Generálny riaditeľSacha Loiseau
Zamestnanci59
Dátum založenia2000
Hlavné sídlo-
Odvetvie-